New insulin pump aims to improve blood sugar control for adults with type 1 diabetes
NCT ID NCT07401901
First seen Feb 11, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tests a new automated insulin delivery system (NMX8) in 230 adults with type 1 diabetes who are not meeting their blood sugar goals. Participants will use either the NMX8 system or another approved system to compare how well they keep blood sugar in a healthy range. The goal is to see if the new system is safe and works better at controlling diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam University Medical Center (Amsterdam UMC)
Amsterdam, Netherlands
-
Azienda Ospedaliera Ospedale Niguarda Cà Granda
Milan, Italy
-
Azienda Ospedaliera Universitaria Federico II
Naples, Italy
-
CHU de Nîmes - Hôpital Universitaire Caremeau
Nîmes, France
-
Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital
Cambridge, United Kingdom
-
Centre Hospitalier Universitaire de Caen
Caen, France
-
Die Praxisgemeinschaft für Endokrinologie und Diabetes
Rostock, Germany
-
Fondazione Policlinico Universitario Agostino Gemelli - Università Cattolica del Sacro Cuore
Roma, Italy
-
Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum
Bad Oeynhausen, Germany
-
Hopital Lariboisiere & Fernand-Widal
Paris, France
-
Hospices Civils de Lyon (DIAB-e CARE)
Lyon, France
-
Hospital Clínico San Carlos
Madrid, Spain
-
Hospital Universitari Clínic de Barcelona
Barcelona, Spain
-
Hospital Universitario La Paz
Madrid, Spain
-
Hôpital Michallon - CHU Grenoble
Grenoble, France
-
Leicester General Hospital
Leicester, United Kingdom
-
Maastricht University Medical Center (UMC)
Maastricht, Netherlands
-
Manchester University NHS Foundation Trust - Manchester Royal Infirmary
Manchester, United Kingdom
-
Policlinico Sant' Orsola - Malpighi
Bologna, Italy
-
ZGT Almelo
Almelo, Netherlands
-
Zentrum für digitale Diabetologie Hamburg
Hamburg, Germany
Conditions
Explore the condition pages connected to this study.